CA2993098C - Method of maximizing epigallocatechin gallate content in tea - Google Patents
Method of maximizing epigallocatechin gallate content in tea Download PDFInfo
- Publication number
- CA2993098C CA2993098C CA2993098A CA2993098A CA2993098C CA 2993098 C CA2993098 C CA 2993098C CA 2993098 A CA2993098 A CA 2993098A CA 2993098 A CA2993098 A CA 2993098A CA 2993098 C CA2993098 C CA 2993098C
- Authority
- CA
- Canada
- Prior art keywords
- tea
- withering
- tea leaf
- bud material
- fewer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 53
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 title claims abstract description 50
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 229940030275 epigallocatechin gallate Drugs 0.000 title claims abstract description 42
- 241001122767 Theaceae Species 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 159
- 235000013616 tea Nutrition 0.000 claims abstract description 152
- 239000000463 material Substances 0.000 claims abstract description 42
- 238000010306 acid treatment Methods 0.000 claims abstract description 10
- 238000007710 freezing Methods 0.000 claims abstract description 10
- 230000008014 freezing Effects 0.000 claims abstract description 10
- 235000020341 brewed tea Nutrition 0.000 claims abstract description 8
- 238000011282 treatment Methods 0.000 claims abstract description 8
- 238000002803 maceration Methods 0.000 claims abstract description 7
- 238000001802 infusion Methods 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 235000005979 Citrus limon Nutrition 0.000 claims description 9
- 244000131522 Citrus pyriformis Species 0.000 claims description 9
- 238000003306 harvesting Methods 0.000 claims description 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 5
- 235000011089 carbon dioxide Nutrition 0.000 claims description 5
- 235000013399 edible fruits Nutrition 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 240000000560 Citrus x paradisi Species 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 230000002879 macerating effect Effects 0.000 claims description 4
- 235000020971 citrus fruits Nutrition 0.000 claims description 3
- 241000207199 Citrus Species 0.000 claims description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 2
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 2
- 239000004571 lime Substances 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 16
- 230000003647 oxidation Effects 0.000 abstract description 15
- 238000010438 heat treatment Methods 0.000 abstract description 5
- 239000002253 acid Substances 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 238000003672 processing method Methods 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 34
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 27
- 235000005487 catechin Nutrition 0.000 description 27
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 26
- 238000001946 ultra-performance liquid chromatography-mass spectrometry Methods 0.000 description 24
- 150000001765 catechin Chemical class 0.000 description 22
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 13
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 13
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 13
- 238000001035 drying Methods 0.000 description 13
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 13
- 235000012734 epicatechin Nutrition 0.000 description 13
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 13
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 11
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 10
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 10
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 10
- 230000008569 process Effects 0.000 description 10
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 235000006468 Thea sinensis Nutrition 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 5
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 229960001948 caffeine Drugs 0.000 description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 5
- 229950001002 cianidanol Drugs 0.000 description 5
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 4
- 235000017491 Bambusa tulda Nutrition 0.000 description 4
- 244000082204 Phyllostachys viridis Species 0.000 description 4
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 4
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 239000011425 bamboo Substances 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000012520 frozen sample Substances 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 235000020334 white tea Nutrition 0.000 description 3
- 240000007524 Camellia sinensis var. sinensis Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 150000002206 flavan-3-ols Chemical class 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 description 1
- 240000008441 Camellia sinensis var. assamica Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000002113 chemopreventative effect Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical class C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 235000020332 matcha tea Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000020339 pu-erh tea Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000014620 theaflavin Nutrition 0.000 description 1
- 235000008118 thearubigins Nutrition 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 235000020338 yellow tea Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/18—Extraction of water soluble tea constituents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Tea And Coffee (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
This invention describes a new method to maximize the epigallocatechin gallate (EGCG) content of brewed tea made using leaves and buds from C. sinensis. Unlike conventional tea processing methods, the method of the invention aims to minimize the leaf withering step, the oxidation step and any heating steps, all of which are present in many conventional tea processing methods. The method of the invention treats minimally withered tea leaf and bud material with an acid treatment and then a maceration treatment, optionally freezing the acid- treated material for storage purposes. The brewed tea resulting from the acid-treated and macerated leaves has a significantly higher EGCG content than conventionally produced teas.
Description
Method of Maximizing Epigallocatechin Gallate Content in Tea FIELD OF THE INVENTION
[0001] This invention relates generally to novel methods of maximizing the extraction of catechins from brewed tea. More specifically, this invention relates to the maximization of epigallocatechin gallate (EGCG) levels in tea made from Camellia sinensis.
BACKGROUND
[0001] This invention relates generally to novel methods of maximizing the extraction of catechins from brewed tea. More specifically, this invention relates to the maximization of epigallocatechin gallate (EGCG) levels in tea made from Camellia sinensis.
BACKGROUND
[0002] The current invention has application to the field of tea brewing and consumption. Tea is produced from the Camellia sinensis plant, a species of evergreen shrub or small tree. Two major varieties of C. sinensis are grown: C. sinensis var. sinensis, and C.
sinensis var. assamica.
The former is used to produce Chinese teas, while the latter is used to produce Indian Assam teas. Forms of tea produced from these varieties of C. sinensis include green, white, yellow, black, oolong, pu-erh and matcha tea. Most of the teas are produced with the leaves exclusively, although some forms of tea also include the twigs and stems.
sinensis var. assamica.
The former is used to produce Chinese teas, while the latter is used to produce Indian Assam teas. Forms of tea produced from these varieties of C. sinensis include green, white, yellow, black, oolong, pu-erh and matcha tea. Most of the teas are produced with the leaves exclusively, although some forms of tea also include the twigs and stems.
[0003] Some forms of tea do not contain any C. sinensis, including many herbal and fruit infusions. This invention does not pertain to teas that do not contain C.
sinensis materials. For the purpose of this disclosure, the term "tea" includes only those beverages produced with material from C. sinensis.
sinensis materials. For the purpose of this disclosure, the term "tea" includes only those beverages produced with material from C. sinensis.
[0004] For the purpose of this invention, the term "brewed tea" refers to a tea-based beverage that results from allowing the C. sinensis plant material to steep in water in order to extract the flavor and chemical compounds from the tea. In general, tea is brewed or steeped using hot water, most typically boiling water or water that is close to the boiling point. Some tea is also "sun tea" that is allowed to brew at ambient temperatures in sunlight. Tea can also be brewed using cold water over a longer period of time, optionally in a refrigerated environment. Any Page 1 of 16 method of combining tea leaves with water to produce a beverage is considered to be "brewed tea" for the purposes of this disclosure. The time that the leaves are allowed to remain in the water can vary from a few seconds up to many hours, depending on the techniques used and the desired strength of the beverage.
[0005] C. sinensis is native to East Asia, Southeast Asia, and the Indian Subcontinent. Today, it is cultivated around the world in tropical and subtropical regions. The plant is usually kept trimmed to less than 2 metres in height in order to facilitate picking. Tea leaves are typically harvested several times during the harvesting season, which begins in March and carries through to November in the Northern Hemisphere. In countries south of the equator, the harvesting season runs October to May. Picking tea typically involves picking a terminal bud and two young leaves. Picking can be done mechanically or by hand.
[0006] After picking, the leaves of C. sinensis begin to wilt and oxidize unless they are heated immediately. Typically, the enzymatic oxidation reaction in the leaves that causes darkening and release of tannins is halted by heating, often simultaneously as the leaves are dried. Tea is conventionally dried for ease of packaging, shipping and storage.
[0007] All teas produced from C. sinensis contain a number of chemical compounds including caffeine, theobromine, theophylline, and polyphenols. Among the polyphenols are flavonoids and catechins. Flavanols (also called flavan-3-ols) are derivatives of flavans that use the 2-pheny1-3,4-dihydro-2H-chromen-3-ol skeleton. The compounds from tea that fall into this group include catechin (C), epicatechin gallate (ECG), epigallocatechin (EGC), epigallocatechin gallate (EGCG), epicatechin (EC), and catechin gallate (CG). C and EC are epimers, while EGC and gallocatechins contain an additional phenolic hydroxyl group when compared to C and EC.
EGCG and EGC are the most abundant catechins in green tea (Williamson et al.
(2011) Moi.
Page 2 of 16 Nutr. Food. Res. 55:864-873).
100081 The catechins contained in tea have recently been of increasing interest due to their strong antioxidant effect, as described in, for example, Zhao B. et.
al.(1989), Cell Biophys. 14, 175, which outlines the scavenging effects of the catechins on active oxygen radicals, and Huang M. T. et al., (1992) Carcinogenesis 13, 947, which outlines the inhibition of tumor initiation and promotion in mouse skin as a result of topical application of catechins.
100091 In addition, research is increasingly demonstrating a cancer chemo-preventive effect of catechins. Singh et al. (2014) Biochem Pharmacol. 82(12): 1807-1821 review a broad range of studies showing that EGCG performs as a powerful antioxidant, preventing oxidative damage in healthy cells and acting as an antiangiogenic and antitumor agent. In addition, Singh mentions the benefits of EGCG in early studies in diabetes, Parkinson's disease, Alzheimer's disease, stroke and obesity.
[0010] Given the increasing interest in tea catechins, and EGCG in particular, there is a need for methods of maximizing the EGCG content of tea in order to take full advantage of its beneficial properties.
SUMMARY OF THE INVENTION
100111 Provided is a method of maximizing EGCG content from tea. In one embodiment, the content of EGCG is maximized by harvesting tea leaf and bud material from C.
sinensis, minimizing the withering time of said leaf and bud material, treating the leaf and bud material with an acid treatment, infusing the treated material in water, and macerating the treated, infused material to produce a final tea product with higher EGCG content.
[0012] The acid treatment may comprise ascorbic and citric acid and may be obtained from citrus fruits or other sources of ascorbic and/or citric acid.
Page 3 of 16 [0013] Optionally, the treated tea leaf and bud material may be subjected to a carefully controlled freezing step in order to maintain shelf life and stability of the EGCG levels within the product. The infusion and maceration may optionally occur after the freezing step.
DETAILED DESCRIPTION
[0014] The following is a detailed description of an embodiment of technology and methods enabling improved catechin levels in tea produced from C. sinensis, and in particularly, improved EGCG levels in tea produced from C. sinensis.
[0015] Following the picking of tea leaves, the leaves begin to wilt and oxidize. This is desirable in tea because it causes the leaves to turn darker as they produce tannins, which create the characteristic flavor of tea. The withering process is carefully controlled by tea producers by monitoring of the humidity, temperature, and air flow around the leaves. It is desirable for the leaves to wither evenly. The darkening, and tannin production, are typically stopped during the drying of the tea, by heating. The ending of the withering process is typically governed by the amount of water loss, usually measured by percent, and usually a moisture reduction of one third to one half is normal. Further moisture reduction occurs later in the conventional tea processing cycle.
[0016] In the present application, it is recommended to allow the leaves to wither for a period of fewer than 16 hours. The withering time can optionally be eliminated entirely by processing using a mobile in-field unit to begin processing the leaves immediately.
Alternatively, withering can be carried out for a short time, such as a few minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, or up to an hour. Withering can also be carried out for a longer time, including 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 11 hours, 12 hours, 13 hours, 14 hours, 15 hours, or any period of time up to 16 hours. Withering Page 4 of 16 can be achieved using standard techniques known in the art of tea production.
The working examples described later in this application use a period of 7 hours for withering. This period was chosen as the average time frame for the leaves to proceed from picking to processing in an average tea harvesting operation.
100171 The withering process reduces the level of catechins in tea, as demonstrated by Chen.
(Chen, C. (1984) Theory in Tea Processing, 51-52, 205-217, Shanghai: Shanghai Science and Technology Press.) As seen in Table 1, below, the catechins in white tea drop significantly during the withering process.
Table 1: The variation of catechins (in mg) of white tea during processing Catechin Fresh Withering 8 Withering 16 Withering 32 Leaves hours hours hours EGC 36.70 24.54 19.62 8.61 GC 23.74 16.56 11.42 4.91 EC + C 24.32 20.76 15.20 10.51 EGCG 122.56 90.08 77.02 55.49 ECG 40.62 31.89 26.31 20.21 Total 247.94 183.83 149.57 109.73 [0018] During the withering process, oxidation begins to occur inside the tea leaves.
Chlorophyll in the tea leaves is degrading, while flavor compounds begin to accumulate. The cell walls of the individual leaf cells begin to break down, which initiates the activity of polyphenol oxidase and peroxidase. These compounds cause oxidation of the cell contents.
Some components of the leaves will degrade into volatile components. During oxidation, the catechins, which are located in the leaf cell vacuoles, are converted into flavonoids ¨ specifically theaflavins and thearubigins. These compounds provide the tea with taste and colour. However, Page 5 of 16 this process also reduces the level of catechins because they are being converted into other compounds. Therefore, it is permissible to allow some oxidation for the purpose of flavor, but ideally, the time from picking to freezing should be minimized in order to prevent oxidation, thereby retaining the maximum level of catechins while not completely compromising flavor profiles.
[0019] Oxidation in standard tea production requires careful control of humidity and oxygen.
Oxidation occurs best at a temperature range of 26.7 to 29.4 '14C (80 to 85 F), and is slowed almost completely at a range of 60 to 65.5 C (140 to 150 F) (Basu & Ullah (1978) Two and A
Bud 25(1): 7-11). For the purposes of this invention, no oxidation, or very limited oxidation is desirable because more of the catechins are left intact. When oxidation is allowed to continue in the leaves, many of the catechins will have been converted, leaving far fewer catechins in the final tea. Thus, unlike in conventional tea processing, the leaves used to produce tea according to this disclosure are not subjected to a specific oxidation step.
[0020] The oxidation process in standard tea production is typically stopped by heating the leaves. This is also referred to as fixing or kill-green. To stop oxidation, the leaves must be heated to a minimum of 65.5 C (150 F). Numerous methods can be used to heat the leaves, including steaming, pan firing, boiling, heated tumbling, heated drying in ovens or similar units, and sun drying, which results in fixing as a result of dehydration rather than heating. Because of the intent to maximize catechins, the disclosed invention does not use a heated fixing step. The intent of the invention is to take the leaves from the picking step to the freezing step as quickly as possible by minimizing any withering and also minimizing any oxidation. The tea leaves in the present invention are subjected to freezing as soon as possible after picking. Unlike in conventional tea processing, in the present disclosure, the combination of the acid treatment and Page 6 of 16 subsequent freezing process acts as a fixing step.
[0021] In general, tea leaves are dried as a final step in their processing.
Drying is a convenient and relatively simple way to keep tea leaves shelf-stable and the process also makes the leaves easier to transport and store. Drying can also potentially enhance the flavor of the tea. Drying is typically achieved using a commercial dryer such as a heater or fluidized bed dryer, an oven, or sun drying. Less common methods include charcoal firing or drying on a heated floor. Drying typically aims to reduce moisture levels to 2-3%, slowing oxidative processes almost completely and making the leaves shelf stable. Unlike conventional tea processing, in the present disclosure, prolonged drying is not a desirable step because it will reduce catechin levels.
[0022] Tea leaves are conventionally dried to approximately one quarter of their original weight.
Typically, 10 grams of leaves/buds are reduced to 2.5 grams, which is used for a typical 250 mL
serving of brewed tea. Often, tea is dried to a point that it contains one to six percent moisture content. Contrary to traditional tea drying methods, the present disclosure aims to avoid such drying. The present disclosure aims to produce a tea from leaves that retain 50 to 100% of their original moisture content at the time of picking. This is achieved by the minimal withering time and subsequent treatment of the leaf and bud material. Shorter withering times result in higher levels of EGCG and other catechins.
[0023] Ascorbic acid has previously been demonstrated to stabilize catechins in green tea (Chen et al. (1998) J. Agric. Food Chem. 46(7): 2512-2516). Chen showed that while catechins are typically unstable and degraded quickly, the addition of acid would increase their stability. Chen demonstrated that adding ascorbic acid to catechins in a sodium phosphate buffer improved their stability for up to 20 hours.
[0024] By using a lemon juice treatment on the harvested and withered tea leaves, thereby Page 7 of 16 providing an acid treatment, the instant invention demonstrates a significant increase in catechin levels. In addition, applicants have demonstrated that the maceration of a lemon-treated sample of tea leaves, coupled with a second infusion, results in 79 times the level of EGCG than a typically-processed tea sample. This increase is surprisingly high in comparison with typically processed teas.
[0025] The following examples illustrate the present invention in more detail and are illustrative of how the invention described herein could be implemented in tea. The initial steps of Example were conducted in North Carolina and the analysis was subsequently conducted in Quebec, Canada. Testing was conducted in October and November of 2016.
[0026] Example 1: Preparation of Samples [00271 The invention described herein was practiced using C. sinensis var.
sinensis leaf obtained from a nursery in North Carolina. Two leaves and a bud were picked from three-year old plants.
The total amount picked was between 70 and 80 grams of plant material. The leaves were allowed to wither naturally on a bamboo rack for seven hours.
[0028] The gathered, withered plant material was divided into 6 separate samples. One sample gave inconclusive results, and another sample was not ultimately tested, so only four samples will be reviewed in this example.
[0029] The four samples were subjected to different treatments as shown in Table 2, below.
Table 2: Sample Treatments # Name Treatment Methodology 1 Steamed 10 grams of plant material was steamed in a bamboo steaming rack with a lid over 95 C boiling water for 40 seconds, then vacuum sealed in plastic and rapidly frozen in controlled conditions at -27 C using dry ice.
2 Processed 10 grams of plant material was steamed in a bamboo steaming rack with a lid over 95 C boiling water for 45 seconds, then left to dry on the bamboo rack to wither for 30 minutes at a temperature of 65 C, and Page 8 of 16 vacuum-sealed. Post-drying weight was 2.6 grams.
3 Lemon- 10 grams of plant material was bathed in approximately 6 tablespoons of treated freshly-squeezed lemon juice for 10 seconds. The bathing step was accomplished using a glass jar, and the leaves were stirred within the lemon juice and were removed from the bath using a strainer. The sample was then vacuum-sealed and rapidly frozen in controlled conditions at -27 C using dry ice.
4 Natural 10 grams of plant material was vacuum-sealed and rapidly frozen in controlled conditions at -27 C using dry ice.
[0030] Samples 1, 3 and 4 were transported on dry ice and shipped to a testing facility in Quebec, Canada. Sample 2 was shipped to the same testing facility but, because it was not frozen, it was treated in the same manner as conventional finished tea and was therefore transported at ambient temperature.
100311 Example 2: Infusion Testing [0032] The treated leaves described in Example 1 were subjected to two infusions. Each sample was infused in 250 mL of 95 C (203 F) water for a duration of four minutes.
Then the liquid was drained and a second 250 mL of 95 C (203 F) water was added to the same leaves for a second infusion. Samples 1, 2 and 4 had the liquid drained for testing. Sample 3 was subjected to a further step of blending for 2 minutes in a blender following the second, 6-minute infusion, and then the final liquid was filtered prior to testing.
[0033] The results for each of the four samples are provided in Tables 3 through 6, below.
Table 3: Results for Sample 1: Steamed Analysis Method Infusion Result 1 4 072 ug/lOg tea Epigallocatechin (EGC) UPLC-MS
pig/lOg tea Catechin (C) UPLC-MS 1 673 ug/lOg tea 2 1 288 mg/lOg tea 1 2 580 mg/lOg tea Epicatechin (EC) UPLC-MS
2 3 037 vigil Og tea Epigallocatechin gallate (EGCG) UPLC-MS 1 6 170 pig/10g tea Page 9 of 16 2 9 387 g/lOg tea 1 3 180 g/lOg tea Epicatechin gallate (ECG) UPLC-MS
2 3 256 g/10g tea 1 560 g/lOg tea Catechin gallate (CG) UPLC-MS
2 927 g/log tea 1 40 mg/lOg tea Caffeine HPLC-UV
2 17 mg/lOg tea USDA 1 5 131 TEAC ' H-ORAC
Spectrofluorimetry 2 6 806 TEAC ' USDA 1 513 mo1/250 mL tea 2 H-ORAC
Spectrofluorimetry 2 513 mo1/250 mL tea 2 I TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in mol TE/100 g of sample.
2 Units to compared Camellia sinensis results Table 4: Results for Sample 2: Processed Analysis Method Infusion Result 1 3034 g/2.6 g tea Epigallocatechin (EGC) UPLC-MS
2 383 g/2.6 g tea 1 1278 42.6 g tea Catechin (C) UPLC-MS
2 1596 g/2.6 g tea 1 3541 g/2.6 g tea Epicatechin (EC) UPLC-MS
2 2760 g/2.6 g tea 1 5318 g/2.6 g tea Epigallocatechin gallate (EGCG) UPLC-MS
2 1201 g/2.6 g tea 1 3363 g/2.6 g tea Epicatechin gallate (ECG) UPLC-MS
2 2979 g/2.6 g tea 1 905 g/2.6 g tea Catechin gallate (CG) UPLC-MS
2 1160 g/2.6 g tea 1 45 mg/2.6 g tea Caffeine HPLC-UV
2 15 mg/2.6 g tea H-ORAC
Spectrofluorimetry 2 26 000 TEAC
USDA 1 703 ilmo1/250 mL tea 2 H-ORAC
Spectrofluorimetry 2 675 mo1/250 mL tea 2 I TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in mol TE/100 g of sample.
2 Units to compared Camellia sinensis results Table 5: Results for Sample 3: Lemon Treated Page 10 of 16 Analysis Method Infusion Result Epigallocatechin (EGC) UPLC-MS 1 14 711 ug/10 g tea 2 60 911 g/10 g tea Catechin (C) UPLC-MS 1 294 ug/10 g tea 2 2 243 ug/10 g tea Epicatechin (EC) UPLC-MS 1 4 322 ug/10 g tea 2 15 281 ug/10 g tea Epigallocatechin gallate (EGCG) UPLC-MS 1 20 604 lig/10 g tea 2 95 156 ug/10 g tea Epicatechin gallate (ECG) UPLC-MS 1 4 798 pig/10 g tea 2 19 852 ug/10 g tea Catechin gallate (CG) UPLC-MS 1 ND' Caffeine HPLC-UV 42 mg/10 g tea 2 16 mg/10 g tea Spectrofluorimetry 2 37 415 TEAC 2 H-ORAC USDA 1 800 pmol/250 mL tea 3 Spectrofluorimetry 2 3 741 mol/250 mL tea 3 ND: Not Detected 2 TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in mai TE/100 g of sample.
3 Units to compared Camellia sinensis results Table 6: Results for Sample 4: Natural Analysis Method Infusion Result Epigallocatechin (EGC) UPLC-MS 1 3 7501.1g/10g tea 2 4 119 ilg/lOg tea Catechin (C) UPLC-MS 1 673 pg/lOg tea 2 1 514 ug/lOg tea Epicatechin (EC) UPLC-MS 1 2 590 Rg/lOg tea 2 3 356 tig/lOg tea Epigallocatechin gallate (EGCG) UPLC-MS 1 6 235 ug/lOg tea 2 8 197 ug/lOg tea Epicatechin gallate (ECG) UPLC-MS 1 2 882 ug/lOg tea 2 4 155 ug/lOg tea Catechin gallate (CG) UPLC-MS 1 583 ug/lOg tea 2 1 225 vig/lOg tea Caffeine HPLC-UV 1 35 mg/lOg tea 2 21 mg/lOg tea Page 11 of 16 Spectrofluorimetry 2 8 100 TEAC 1 H ORAC USDA 1 547 mmo1/250 mL tea 2 - Spectrofluorimetry 2 810 ttmo1/250 mL tea 2 TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in 1.tmol TE/100 g of sample.
2 Units to compared Camellia sinensis results [0034] Reviewing the results from the tables presented above, it can easily be seen that all the frozen samples of tea produced higher levels of EGCG than Sample 2, which was dried and processed in the manner of typical tea processing. Furthermore, the dried sample exhibited a significant drop in EGCG level in the second infusion, resulting in less than 25% of the amount of EGCG recovered in the first infusion. Additionally, the frozen samples all had higher EGCG
levels than the dried sample, and unlike the processed sample where the values dropped upon the second infusion, the values for ECGC were significantly higher on the second infusion for all three of the frozen samples.
[0035] The natural leaf sample EGCG levels were 221% higher than the processed sample. The steamed leaf sample EGCG levels were 238% higher than the processed sample, and 108%
higher than the natural leaf sample. The lemon-treated sample had overall EGCG
levels that were 1,776% higher than the processed sample, and 802% higher than the natural leaf sample.
Notably, the EGCG levels on the lemon-treated sample, which were already superior to the other tested samples, nearly quadrupled following the maceration after the second infusion. The sample resulted in EGCG levels that were 7,923% higher following the second infusion and maceration than the second infusion of the processed sample, and 1160% more EGCG on the second infusion in comparison to the natural leaf sample.
[0036] Although various representative embodiments of this invention have been described above with a certain degree of particularity, those skilled in the art could make numerous Page 12 of 16 alterations to the disclosed embodiments without departing from the spirit or scope of the inventive subject matter set forth in the specification and claims. In some instances, in methodologies directly or indirectly set forth herein, various steps and operations are described in one possible order of operation, but those skilled in the art will recognize that steps and operations may be rearranged, replaced, or eliminated without necessarily departing from the spirit and scope of the present invention. It is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative only and not limiting. Changes in detail or structure may be made without departing from the spirit of the invention as defined in the appended claims.
100371 Although the present invention has been described with reference to the embodiments outlined above, various alternatives, modifications, variations, improvements and/or substantial equivalents, whether known or that are or may be presently foreseen, may become apparent to those having at least ordinary skill in the art. Listing the steps of a method in a certain order does not constitute any limitation on the order of the steps of the method.
Accordingly, the embodiments of the invention set forth above are intended to be illustrative, not limiting.
Persons skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention. Therefore, the invention is intended to embrace all known or earlier developed alternatives, modifications, variations, improvements, and/or substantial equivalents.
Page 13 of 16 I. A method of increasing the content of epigallocatechin gallate in brewed tea, comprising a) harvesting tea leaf and bud material from C. sinensis;
b) allowing said tea leaf and bud material to wither for fewer than 16 hours;
c) treating said tea leaf and bud material with an acid treatment;
d) infusing said treated tea leaf and bud material in water; and e) macerating said treated tea leaf and bud material in the water to produce a brewed, macerated tea beverage.
2. The method of claim 1 wherein said acid treatment is a result of treatment in the juice of one or more fruits originating from the Citrus genus.
3. The method of claim 2 wherein said one or more fruits are selected from the group consisting of:
a) lemon;
b) orange;
c) lime;
d) grapefruit; and e) pomelo 4. The method of claim 1 wherein said infusion in water is conducted with water that has a temperature between 0 and 100 degrees Celsius.
5. The method of claim 1 wherein said water infusion step is conducted for up to 20 hours.
6. The method of claim 1 wherein said treated tea leaf and bud material is subjected to rapid freezing following the acid treatment to preserve the stability of the leaf and bud 13A of 16 Date Recue/Date Received 2020-07-03 material, and further wherein in the infusing and macerating steps occur at a later time using the frozen tea leaf and bud material.
7. The method of claim 1 wherein said maceration step is accomplished using a tool selected from the group consisting of a blender, food processor, hand mixer, knife or other chopping instrument.
13B of 16 Date Recue/Date Received 2020-07-03
EGCG and EGC are the most abundant catechins in green tea (Williamson et al.
(2011) Moi.
Page 2 of 16 Nutr. Food. Res. 55:864-873).
100081 The catechins contained in tea have recently been of increasing interest due to their strong antioxidant effect, as described in, for example, Zhao B. et.
al.(1989), Cell Biophys. 14, 175, which outlines the scavenging effects of the catechins on active oxygen radicals, and Huang M. T. et al., (1992) Carcinogenesis 13, 947, which outlines the inhibition of tumor initiation and promotion in mouse skin as a result of topical application of catechins.
100091 In addition, research is increasingly demonstrating a cancer chemo-preventive effect of catechins. Singh et al. (2014) Biochem Pharmacol. 82(12): 1807-1821 review a broad range of studies showing that EGCG performs as a powerful antioxidant, preventing oxidative damage in healthy cells and acting as an antiangiogenic and antitumor agent. In addition, Singh mentions the benefits of EGCG in early studies in diabetes, Parkinson's disease, Alzheimer's disease, stroke and obesity.
[0010] Given the increasing interest in tea catechins, and EGCG in particular, there is a need for methods of maximizing the EGCG content of tea in order to take full advantage of its beneficial properties.
SUMMARY OF THE INVENTION
100111 Provided is a method of maximizing EGCG content from tea. In one embodiment, the content of EGCG is maximized by harvesting tea leaf and bud material from C.
sinensis, minimizing the withering time of said leaf and bud material, treating the leaf and bud material with an acid treatment, infusing the treated material in water, and macerating the treated, infused material to produce a final tea product with higher EGCG content.
[0012] The acid treatment may comprise ascorbic and citric acid and may be obtained from citrus fruits or other sources of ascorbic and/or citric acid.
Page 3 of 16 [0013] Optionally, the treated tea leaf and bud material may be subjected to a carefully controlled freezing step in order to maintain shelf life and stability of the EGCG levels within the product. The infusion and maceration may optionally occur after the freezing step.
DETAILED DESCRIPTION
[0014] The following is a detailed description of an embodiment of technology and methods enabling improved catechin levels in tea produced from C. sinensis, and in particularly, improved EGCG levels in tea produced from C. sinensis.
[0015] Following the picking of tea leaves, the leaves begin to wilt and oxidize. This is desirable in tea because it causes the leaves to turn darker as they produce tannins, which create the characteristic flavor of tea. The withering process is carefully controlled by tea producers by monitoring of the humidity, temperature, and air flow around the leaves. It is desirable for the leaves to wither evenly. The darkening, and tannin production, are typically stopped during the drying of the tea, by heating. The ending of the withering process is typically governed by the amount of water loss, usually measured by percent, and usually a moisture reduction of one third to one half is normal. Further moisture reduction occurs later in the conventional tea processing cycle.
[0016] In the present application, it is recommended to allow the leaves to wither for a period of fewer than 16 hours. The withering time can optionally be eliminated entirely by processing using a mobile in-field unit to begin processing the leaves immediately.
Alternatively, withering can be carried out for a short time, such as a few minutes, 5 minutes, 10 minutes, 15 minutes, 30 minutes, 45 minutes, or up to an hour. Withering can also be carried out for a longer time, including 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours, 7 hours, 8 hours, 9 hours, 10 hours, 11 hours, 12 hours, 13 hours, 14 hours, 15 hours, or any period of time up to 16 hours. Withering Page 4 of 16 can be achieved using standard techniques known in the art of tea production.
The working examples described later in this application use a period of 7 hours for withering. This period was chosen as the average time frame for the leaves to proceed from picking to processing in an average tea harvesting operation.
100171 The withering process reduces the level of catechins in tea, as demonstrated by Chen.
(Chen, C. (1984) Theory in Tea Processing, 51-52, 205-217, Shanghai: Shanghai Science and Technology Press.) As seen in Table 1, below, the catechins in white tea drop significantly during the withering process.
Table 1: The variation of catechins (in mg) of white tea during processing Catechin Fresh Withering 8 Withering 16 Withering 32 Leaves hours hours hours EGC 36.70 24.54 19.62 8.61 GC 23.74 16.56 11.42 4.91 EC + C 24.32 20.76 15.20 10.51 EGCG 122.56 90.08 77.02 55.49 ECG 40.62 31.89 26.31 20.21 Total 247.94 183.83 149.57 109.73 [0018] During the withering process, oxidation begins to occur inside the tea leaves.
Chlorophyll in the tea leaves is degrading, while flavor compounds begin to accumulate. The cell walls of the individual leaf cells begin to break down, which initiates the activity of polyphenol oxidase and peroxidase. These compounds cause oxidation of the cell contents.
Some components of the leaves will degrade into volatile components. During oxidation, the catechins, which are located in the leaf cell vacuoles, are converted into flavonoids ¨ specifically theaflavins and thearubigins. These compounds provide the tea with taste and colour. However, Page 5 of 16 this process also reduces the level of catechins because they are being converted into other compounds. Therefore, it is permissible to allow some oxidation for the purpose of flavor, but ideally, the time from picking to freezing should be minimized in order to prevent oxidation, thereby retaining the maximum level of catechins while not completely compromising flavor profiles.
[0019] Oxidation in standard tea production requires careful control of humidity and oxygen.
Oxidation occurs best at a temperature range of 26.7 to 29.4 '14C (80 to 85 F), and is slowed almost completely at a range of 60 to 65.5 C (140 to 150 F) (Basu & Ullah (1978) Two and A
Bud 25(1): 7-11). For the purposes of this invention, no oxidation, or very limited oxidation is desirable because more of the catechins are left intact. When oxidation is allowed to continue in the leaves, many of the catechins will have been converted, leaving far fewer catechins in the final tea. Thus, unlike in conventional tea processing, the leaves used to produce tea according to this disclosure are not subjected to a specific oxidation step.
[0020] The oxidation process in standard tea production is typically stopped by heating the leaves. This is also referred to as fixing or kill-green. To stop oxidation, the leaves must be heated to a minimum of 65.5 C (150 F). Numerous methods can be used to heat the leaves, including steaming, pan firing, boiling, heated tumbling, heated drying in ovens or similar units, and sun drying, which results in fixing as a result of dehydration rather than heating. Because of the intent to maximize catechins, the disclosed invention does not use a heated fixing step. The intent of the invention is to take the leaves from the picking step to the freezing step as quickly as possible by minimizing any withering and also minimizing any oxidation. The tea leaves in the present invention are subjected to freezing as soon as possible after picking. Unlike in conventional tea processing, in the present disclosure, the combination of the acid treatment and Page 6 of 16 subsequent freezing process acts as a fixing step.
[0021] In general, tea leaves are dried as a final step in their processing.
Drying is a convenient and relatively simple way to keep tea leaves shelf-stable and the process also makes the leaves easier to transport and store. Drying can also potentially enhance the flavor of the tea. Drying is typically achieved using a commercial dryer such as a heater or fluidized bed dryer, an oven, or sun drying. Less common methods include charcoal firing or drying on a heated floor. Drying typically aims to reduce moisture levels to 2-3%, slowing oxidative processes almost completely and making the leaves shelf stable. Unlike conventional tea processing, in the present disclosure, prolonged drying is not a desirable step because it will reduce catechin levels.
[0022] Tea leaves are conventionally dried to approximately one quarter of their original weight.
Typically, 10 grams of leaves/buds are reduced to 2.5 grams, which is used for a typical 250 mL
serving of brewed tea. Often, tea is dried to a point that it contains one to six percent moisture content. Contrary to traditional tea drying methods, the present disclosure aims to avoid such drying. The present disclosure aims to produce a tea from leaves that retain 50 to 100% of their original moisture content at the time of picking. This is achieved by the minimal withering time and subsequent treatment of the leaf and bud material. Shorter withering times result in higher levels of EGCG and other catechins.
[0023] Ascorbic acid has previously been demonstrated to stabilize catechins in green tea (Chen et al. (1998) J. Agric. Food Chem. 46(7): 2512-2516). Chen showed that while catechins are typically unstable and degraded quickly, the addition of acid would increase their stability. Chen demonstrated that adding ascorbic acid to catechins in a sodium phosphate buffer improved their stability for up to 20 hours.
[0024] By using a lemon juice treatment on the harvested and withered tea leaves, thereby Page 7 of 16 providing an acid treatment, the instant invention demonstrates a significant increase in catechin levels. In addition, applicants have demonstrated that the maceration of a lemon-treated sample of tea leaves, coupled with a second infusion, results in 79 times the level of EGCG than a typically-processed tea sample. This increase is surprisingly high in comparison with typically processed teas.
[0025] The following examples illustrate the present invention in more detail and are illustrative of how the invention described herein could be implemented in tea. The initial steps of Example were conducted in North Carolina and the analysis was subsequently conducted in Quebec, Canada. Testing was conducted in October and November of 2016.
[0026] Example 1: Preparation of Samples [00271 The invention described herein was practiced using C. sinensis var.
sinensis leaf obtained from a nursery in North Carolina. Two leaves and a bud were picked from three-year old plants.
The total amount picked was between 70 and 80 grams of plant material. The leaves were allowed to wither naturally on a bamboo rack for seven hours.
[0028] The gathered, withered plant material was divided into 6 separate samples. One sample gave inconclusive results, and another sample was not ultimately tested, so only four samples will be reviewed in this example.
[0029] The four samples were subjected to different treatments as shown in Table 2, below.
Table 2: Sample Treatments # Name Treatment Methodology 1 Steamed 10 grams of plant material was steamed in a bamboo steaming rack with a lid over 95 C boiling water for 40 seconds, then vacuum sealed in plastic and rapidly frozen in controlled conditions at -27 C using dry ice.
2 Processed 10 grams of plant material was steamed in a bamboo steaming rack with a lid over 95 C boiling water for 45 seconds, then left to dry on the bamboo rack to wither for 30 minutes at a temperature of 65 C, and Page 8 of 16 vacuum-sealed. Post-drying weight was 2.6 grams.
3 Lemon- 10 grams of plant material was bathed in approximately 6 tablespoons of treated freshly-squeezed lemon juice for 10 seconds. The bathing step was accomplished using a glass jar, and the leaves were stirred within the lemon juice and were removed from the bath using a strainer. The sample was then vacuum-sealed and rapidly frozen in controlled conditions at -27 C using dry ice.
4 Natural 10 grams of plant material was vacuum-sealed and rapidly frozen in controlled conditions at -27 C using dry ice.
[0030] Samples 1, 3 and 4 were transported on dry ice and shipped to a testing facility in Quebec, Canada. Sample 2 was shipped to the same testing facility but, because it was not frozen, it was treated in the same manner as conventional finished tea and was therefore transported at ambient temperature.
100311 Example 2: Infusion Testing [0032] The treated leaves described in Example 1 were subjected to two infusions. Each sample was infused in 250 mL of 95 C (203 F) water for a duration of four minutes.
Then the liquid was drained and a second 250 mL of 95 C (203 F) water was added to the same leaves for a second infusion. Samples 1, 2 and 4 had the liquid drained for testing. Sample 3 was subjected to a further step of blending for 2 minutes in a blender following the second, 6-minute infusion, and then the final liquid was filtered prior to testing.
[0033] The results for each of the four samples are provided in Tables 3 through 6, below.
Table 3: Results for Sample 1: Steamed Analysis Method Infusion Result 1 4 072 ug/lOg tea Epigallocatechin (EGC) UPLC-MS
pig/lOg tea Catechin (C) UPLC-MS 1 673 ug/lOg tea 2 1 288 mg/lOg tea 1 2 580 mg/lOg tea Epicatechin (EC) UPLC-MS
2 3 037 vigil Og tea Epigallocatechin gallate (EGCG) UPLC-MS 1 6 170 pig/10g tea Page 9 of 16 2 9 387 g/lOg tea 1 3 180 g/lOg tea Epicatechin gallate (ECG) UPLC-MS
2 3 256 g/10g tea 1 560 g/lOg tea Catechin gallate (CG) UPLC-MS
2 927 g/log tea 1 40 mg/lOg tea Caffeine HPLC-UV
2 17 mg/lOg tea USDA 1 5 131 TEAC ' H-ORAC
Spectrofluorimetry 2 6 806 TEAC ' USDA 1 513 mo1/250 mL tea 2 H-ORAC
Spectrofluorimetry 2 513 mo1/250 mL tea 2 I TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in mol TE/100 g of sample.
2 Units to compared Camellia sinensis results Table 4: Results for Sample 2: Processed Analysis Method Infusion Result 1 3034 g/2.6 g tea Epigallocatechin (EGC) UPLC-MS
2 383 g/2.6 g tea 1 1278 42.6 g tea Catechin (C) UPLC-MS
2 1596 g/2.6 g tea 1 3541 g/2.6 g tea Epicatechin (EC) UPLC-MS
2 2760 g/2.6 g tea 1 5318 g/2.6 g tea Epigallocatechin gallate (EGCG) UPLC-MS
2 1201 g/2.6 g tea 1 3363 g/2.6 g tea Epicatechin gallate (ECG) UPLC-MS
2 2979 g/2.6 g tea 1 905 g/2.6 g tea Catechin gallate (CG) UPLC-MS
2 1160 g/2.6 g tea 1 45 mg/2.6 g tea Caffeine HPLC-UV
2 15 mg/2.6 g tea H-ORAC
Spectrofluorimetry 2 26 000 TEAC
USDA 1 703 ilmo1/250 mL tea 2 H-ORAC
Spectrofluorimetry 2 675 mo1/250 mL tea 2 I TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in mol TE/100 g of sample.
2 Units to compared Camellia sinensis results Table 5: Results for Sample 3: Lemon Treated Page 10 of 16 Analysis Method Infusion Result Epigallocatechin (EGC) UPLC-MS 1 14 711 ug/10 g tea 2 60 911 g/10 g tea Catechin (C) UPLC-MS 1 294 ug/10 g tea 2 2 243 ug/10 g tea Epicatechin (EC) UPLC-MS 1 4 322 ug/10 g tea 2 15 281 ug/10 g tea Epigallocatechin gallate (EGCG) UPLC-MS 1 20 604 lig/10 g tea 2 95 156 ug/10 g tea Epicatechin gallate (ECG) UPLC-MS 1 4 798 pig/10 g tea 2 19 852 ug/10 g tea Catechin gallate (CG) UPLC-MS 1 ND' Caffeine HPLC-UV 42 mg/10 g tea 2 16 mg/10 g tea Spectrofluorimetry 2 37 415 TEAC 2 H-ORAC USDA 1 800 pmol/250 mL tea 3 Spectrofluorimetry 2 3 741 mol/250 mL tea 3 ND: Not Detected 2 TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in mai TE/100 g of sample.
3 Units to compared Camellia sinensis results Table 6: Results for Sample 4: Natural Analysis Method Infusion Result Epigallocatechin (EGC) UPLC-MS 1 3 7501.1g/10g tea 2 4 119 ilg/lOg tea Catechin (C) UPLC-MS 1 673 pg/lOg tea 2 1 514 ug/lOg tea Epicatechin (EC) UPLC-MS 1 2 590 Rg/lOg tea 2 3 356 tig/lOg tea Epigallocatechin gallate (EGCG) UPLC-MS 1 6 235 ug/lOg tea 2 8 197 ug/lOg tea Epicatechin gallate (ECG) UPLC-MS 1 2 882 ug/lOg tea 2 4 155 ug/lOg tea Catechin gallate (CG) UPLC-MS 1 583 ug/lOg tea 2 1 225 vig/lOg tea Caffeine HPLC-UV 1 35 mg/lOg tea 2 21 mg/lOg tea Page 11 of 16 Spectrofluorimetry 2 8 100 TEAC 1 H ORAC USDA 1 547 mmo1/250 mL tea 2 - Spectrofluorimetry 2 810 ttmo1/250 mL tea 2 TEAC: Trolox Equivalent Antioxidants Capacity. Results expressed in 1.tmol TE/100 g of sample.
2 Units to compared Camellia sinensis results [0034] Reviewing the results from the tables presented above, it can easily be seen that all the frozen samples of tea produced higher levels of EGCG than Sample 2, which was dried and processed in the manner of typical tea processing. Furthermore, the dried sample exhibited a significant drop in EGCG level in the second infusion, resulting in less than 25% of the amount of EGCG recovered in the first infusion. Additionally, the frozen samples all had higher EGCG
levels than the dried sample, and unlike the processed sample where the values dropped upon the second infusion, the values for ECGC were significantly higher on the second infusion for all three of the frozen samples.
[0035] The natural leaf sample EGCG levels were 221% higher than the processed sample. The steamed leaf sample EGCG levels were 238% higher than the processed sample, and 108%
higher than the natural leaf sample. The lemon-treated sample had overall EGCG
levels that were 1,776% higher than the processed sample, and 802% higher than the natural leaf sample.
Notably, the EGCG levels on the lemon-treated sample, which were already superior to the other tested samples, nearly quadrupled following the maceration after the second infusion. The sample resulted in EGCG levels that were 7,923% higher following the second infusion and maceration than the second infusion of the processed sample, and 1160% more EGCG on the second infusion in comparison to the natural leaf sample.
[0036] Although various representative embodiments of this invention have been described above with a certain degree of particularity, those skilled in the art could make numerous Page 12 of 16 alterations to the disclosed embodiments without departing from the spirit or scope of the inventive subject matter set forth in the specification and claims. In some instances, in methodologies directly or indirectly set forth herein, various steps and operations are described in one possible order of operation, but those skilled in the art will recognize that steps and operations may be rearranged, replaced, or eliminated without necessarily departing from the spirit and scope of the present invention. It is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative only and not limiting. Changes in detail or structure may be made without departing from the spirit of the invention as defined in the appended claims.
100371 Although the present invention has been described with reference to the embodiments outlined above, various alternatives, modifications, variations, improvements and/or substantial equivalents, whether known or that are or may be presently foreseen, may become apparent to those having at least ordinary skill in the art. Listing the steps of a method in a certain order does not constitute any limitation on the order of the steps of the method.
Accordingly, the embodiments of the invention set forth above are intended to be illustrative, not limiting.
Persons skilled in the art will recognize that changes may be made in form and detail without departing from the spirit and scope of the invention. Therefore, the invention is intended to embrace all known or earlier developed alternatives, modifications, variations, improvements, and/or substantial equivalents.
Page 13 of 16 I. A method of increasing the content of epigallocatechin gallate in brewed tea, comprising a) harvesting tea leaf and bud material from C. sinensis;
b) allowing said tea leaf and bud material to wither for fewer than 16 hours;
c) treating said tea leaf and bud material with an acid treatment;
d) infusing said treated tea leaf and bud material in water; and e) macerating said treated tea leaf and bud material in the water to produce a brewed, macerated tea beverage.
2. The method of claim 1 wherein said acid treatment is a result of treatment in the juice of one or more fruits originating from the Citrus genus.
3. The method of claim 2 wherein said one or more fruits are selected from the group consisting of:
a) lemon;
b) orange;
c) lime;
d) grapefruit; and e) pomelo 4. The method of claim 1 wherein said infusion in water is conducted with water that has a temperature between 0 and 100 degrees Celsius.
5. The method of claim 1 wherein said water infusion step is conducted for up to 20 hours.
6. The method of claim 1 wherein said treated tea leaf and bud material is subjected to rapid freezing following the acid treatment to preserve the stability of the leaf and bud 13A of 16 Date Recue/Date Received 2020-07-03 material, and further wherein in the infusing and macerating steps occur at a later time using the frozen tea leaf and bud material.
7. The method of claim 1 wherein said maceration step is accomplished using a tool selected from the group consisting of a blender, food processor, hand mixer, knife or other chopping instrument.
13B of 16 Date Recue/Date Received 2020-07-03
Claims (19)
1. A method of increasing the content of epigallocatechin gallate in brewed tea, comprising:
a) harvesting tea leaf and bud material from C. sinensis;
b) withering said tea leaf and bud material for fewer than 16 hours, or no withering;
c) treating said tea leaf and bud material with an acid treatment; and d) freezing rapidly said treated tea leaf and bud material.
a) harvesting tea leaf and bud material from C. sinensis;
b) withering said tea leaf and bud material for fewer than 16 hours, or no withering;
c) treating said tea leaf and bud material with an acid treatment; and d) freezing rapidly said treated tea leaf and bud material.
2. The method of claim 1, further comprises e) infusing said treated tea leaf and bud material in water.
3. The method of claim 2, further comprises f) macerating said treated tea leaf and bud material in the water to produce a brewed, macerated tea beverage.
4. The method of any one of claims 1-3 wherein said acid treatment is a result of treatment in the juice of one or more fruits originating from the Citrus genus.
5. The method of claim 4 wherein said one or more fruits are selected from the group consisting of:
a) lemon;
b) orange;
c) lime;
d) grapefruit; and e) pomelo.
a) lemon;
b) orange;
c) lime;
d) grapefruit; and e) pomelo.
6. The method of claim 2 or 3 wherein said infusion in water is conducted with water that has a temperature between 0 and 100 degrees Celsius.
7. The method of claim 2, 3, or 6 wherein said water infusion step is conducted for up to 20 hours.
14 of 16 Date Recue/Date Received 2020-07-03
14 of 16 Date Recue/Date Received 2020-07-03
8. The method of claim 3 wherein said maceration step is accomplished using a tool selected from the group consisting of a blender, food processor, hand mixer, knife, and other chopping instrument.
9. The method of any one of claims 1-8 wherein b) withering said tea leaf and bud material for fewer than 14 hours.
10. The method of any one of claims 1-9 wherein b) withering said tea leaf and bud material for fewer than 8 hours.
11. The method of any one of claims 1-10 wherein b) withering said tea leaf and bud material for fewer than 7 hours.
12. The method of any one of claims 1-11 wherein b) withering said tea leaf and bud material for fewer than 1 hour.
13. The method of any one of claims 1-12 wherein b) withering said tea leaf and bud material for fewer than 45 minutes.
14. The method of any one of claims 1-13 wherein b) withering said tea leaf and bud material for fewer than 30 minutes.
15. The method of any one of claims 1-14 wherein b) withering said tea leaf and bud material for fewer than 15 minutes.
16. The method of any one of claims 1-15 wherein b) withering said tea leaf and bud material for fewer than 10 minutes.
17. The method of any one of claims 1-16 wherein b) withering said tea leaf and bud material for fewer than 5 minutes.
15 of 16 Date Recue/Date Received 2020-07-03
15 of 16 Date Recue/Date Received 2020-07-03
18. The method of any one of claims 1-8, wherein b) no withering.
19. The method of any one of claims 1-18 wherein d) comprises freezing said tea leaf and bud material with dry ice.
16 of 16 Date Recue/Date Received 2020-07-03
16 of 16 Date Recue/Date Received 2020-07-03
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2993098A CA2993098C (en) | 2018-01-26 | 2018-01-26 | Method of maximizing epigallocatechin gallate content in tea |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2993098A CA2993098C (en) | 2018-01-26 | 2018-01-26 | Method of maximizing epigallocatechin gallate content in tea |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2993098A1 CA2993098A1 (en) | 2019-07-26 |
CA2993098C true CA2993098C (en) | 2021-04-27 |
Family
ID=67391107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2993098A Active CA2993098C (en) | 2018-01-26 | 2018-01-26 | Method of maximizing epigallocatechin gallate content in tea |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2993098C (en) |
-
2018
- 2018-01-26 CA CA2993098A patent/CA2993098C/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2993098A1 (en) | 2019-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7041312B2 (en) | Semi-fermented tea leaves, flavored semi-fermented tea leaves, mixed tea leaves containing semi-fermented tea leaves or flavored semi-fermented tea leaves, semi-fermented tea leaves, flavored semi-fermented tea leaves or extracts from mixed tea leaves, foods and drinks containing extracts | |
Kosińska et al. | Antioxidant capacity of tea: effect of processing and storage | |
EP2222181B1 (en) | Process for manufacturing tea products | |
EP2334192B1 (en) | Process for manufacturing tea products | |
JP2009291219A (en) | Cold water infusing leaf tea | |
CN101189994A (en) | Fermentation tea and preparation method thereof | |
US11260045B2 (en) | Method of maximizing epigallocatechin gallate content in tea | |
CA2403396C (en) | Cold water soluble tea | |
KR101756340B1 (en) | Fermented green tea and method for manufacturing thereof | |
Singh et al. | Processing technology and health benefits of green tea | |
KR20130066958A (en) | Manufacturing method for tea using the fruit, leaf, stem, and root of momordica charantia having high antioxidant activity and high contents of phytochemical | |
Moodley et al. | Nutritional quality and acceptability of Buddleja saligna herbal tea | |
JP6088544B2 (en) | How to make tea products | |
KR100950780B1 (en) | A sampling method for extracting to tea leaf | |
KR101416492B1 (en) | Fermented Tea Using Jujube Leaves and Green Tea Leaves and There of Manufacturing Method | |
CA2993098C (en) | Method of maximizing epigallocatechin gallate content in tea | |
KR101996467B1 (en) | Method for producing healthful onion juice comprising green tea concentrate | |
Sivakumaran et al. | Bioactivity of fruit teas and tisanes –A review | |
KR101127669B1 (en) | An easy and quick tea manufacturing method of phyllostachys pubescence leaves | |
KR101282960B1 (en) | Method of preparing green tea with excellent preference | |
KR101987347B1 (en) | Method for producing aronia leaves tea and aronia leaves tea produced by the same method | |
KR102410975B1 (en) | A method of preparing tea using green tea leaves and arctium lappa and tea prepared therefrom | |
JP5769994B2 (en) | Tea product manufacturing method | |
RU2737354C1 (en) | Green tea production method | |
KR20230143660A (en) | Fermented green tea through lactic acid bacteria fermentation and manufacturing method thereof |